Harnessing AI-Powered Patient Identification to Accelerate Trial Enrollment
Time: 11:30 am
day: Day One PM
Details:
- Rapidly identifying eligible rare disease patients using AI to analyze medical records (EMR), claims databases, genetic testing partnerships and registries, cutting recruitment timelines by months
- Improving enrollment accuracy by targeting patients who precisely fit trial criteria (both interventional and natural history trials), lowering screen failure rates and cutting costs
- Enhancing recruitment efficiency with data-driven patient targeting to maximize trial enrollment success
